Deafness with labyrinthine aplasia, microtia, and microdontia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:90024OMIM:610706Q16.5
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

Conical toothHP:0000698High hypermetropiaHP:0008499
Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Jan 2026CAPRELSA: New indication approved
FDAcompleted
Apr 2011

CAPRELSA(r): FDA approved

Treatment of asymptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

CAPRELSA(r)

vandetanib· Genzyme Corporation■ Boxed WarningOrphan Drug

Treatment of asymptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease

No actively recruiting trials found for Deafness with labyrinthine aplasia, microtia, and microdontia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Deafness with labyrinthine aplasia, microtia, and microdontia community →

No specialists are currently listed for Deafness with labyrinthine aplasia, microtia, and microdontia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Deafness with labyrinthine aplasia, microtia, and microdontia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Deafness with labyrinthine aplasia, microtia, and microdontiaForum →

No community posts yet. Be the first to share your experience with Deafness with labyrinthine aplasia, microtia, and microdontia.

Start the conversation →

Latest news about Deafness with labyrinthine aplasia, microtia, and microdontia

No recent news articles for Deafness with labyrinthine aplasia, microtia, and microdontia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Deafness with labyrinthine aplasia, microtia, and microdontia

What treatment and support options exist for Deafness with labyrinthine aplasia, microtia, and microdontia?

1 patient support program are currently tracked on UniteRare for Deafness with labyrinthine aplasia, microtia, and microdontia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.